2024-03-06 REL RCSB RCSB RCSB 2020-03-04 2020-05-13 2020-05-13 2024-03-06 National Institutes of Health/Office of the Director DP2EB020402 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) R35GM134867 United States National Institutes of Health/Office of the Director S10OD021634 United States Cryo-EM structure of anti-CRISPR AcrIF9, bound to the type I-F crRNA-guided CRISPR surveillance complex Hirschi M Santiago-Frangos A type I-F CRISPR RNA-guided surveillance complex, Csy complex, IMMUNE SYSTEM-RNA complex Hirschi M Lu WT Santiago-Frangos A Wilkinson R Golden SM Davidson AR Lander GC Wiedenheft B AcrIF9 tethers non-sequence specific dsDNA to the CRISPR RNA-guided surveillance complex. Nat Commun UK 11 2730 2730 2020 32483187 doi:10.1038/s41467-020-16512-1 2041-1723 EMD-21517 other EM volume 6w1x FULLOVERLAP Anti-CRISPR AcrIF9 bound to the type I-F crRNA-guided CRISPR surveillance complex Anti-CRISPR AcrIF9 bound to the type I-F crRNA-guided CRISPR surveillance complex 0 1 2 3 4 5 6 Type I-F crRNA-guided CRISPR surveillance complex 1 1 2 3 4 5 Pseudomonas aeruginosa Anti-CRISPR AcrIF9 1 6 Proteus penneri CRISPR-associated protein Csy1 Pseudomonas aeruginosa 0.049194167999999996 1 Escherichia coli LEVO MTSPLPTPTWQELRQFIESFIQERLQGKLDKLQPDEDDKRQTLLATHRREAWLADAARRVGQLQLVTHTLKPIHPDARGS NLHSLPQAPGQPGLAGSHELGDRLVSDVVGNAAALDVFKFLSLQYQGKNLLNWLTEDSAEALQALSDNAEQAREWRQAFI GITTVKGAPASHSLAKQLYFPLPGSGYHLLAPLFPTSLVHHVHALLREARFGDAAKAAREARSRQESWPHGFSEYPNLAI QKFGGTKPQNISQLNNERRGENWLLPSLPPNWQRQNVNAPMRHSSVFEHDFGRTPEVSRLTRTLQRFLAKTVHNNLAIRQ RRAQLVAQICDEALQYAARLRELEPGWSATPGCQLHDAEQLWLDPLRAQTDETFLQRRLRGDWPAEVGNRFANWLNRAVS SDSQILGSPEAAQWSQELSKELTMFKEILEDERD Q02ML9 Type I-F CRISPR-associated protein Csy2 Pseudomonas aeruginosa 0.036244074 1 Escherichia coli LEVO MSVTDPEALLLLPRLSIQNANAISSPLTWGFPSPGAFTGFVHALQRRVGISLDIELDGVGIVCHRFEAQISQPAGKRTKV FNLTRNPLNRDGSTAAIVEEGRAHLEVSLLLGVHGDGLDDHPAQEIARQVQEQAGAMRLAGGSILPWCNERFPAPNAELL MLGGSDEQRRKNQRRLTRRLLPGFALVSREALLQQHLETLRTTLPEATTLDALLDLCRINFEPPATSSEEEASPPDAAWQ VRDKPGWLVPIPAGYNALSPLYLPGEVRNARDRETPLRFVENLFGLGEWLSPHRVAALSDLLWYHHAEPDKGLYRWSTPR FVEHAIA B3G161 CRISPR-associated protein Csy3 Pseudomonas aeruginosa 0.039778593999999994 6 Escherichia coli LEVO MKSSHHHHHHENLYFQSNASKPILSTASVLAFERKLDPSDALMSAGAWAQRDASQEWPAVTVREKSVRGTISNRLKTKDR DPAKLDASIQSPNLQTVDVANLPSDADTLKVRFTLRVLGGAGTPSACNDAAYRDKLLQTVATYVNDQGFAELARRYAHNL ANARFLWRNRVGAEAVEVRINHIRQGEVARAWRFDALAIGLRDFKADAELDALAELIASGLSGSGHVLLEVVAFARIGDG QEVFPSQELILDKGDKKGQKSKTLYSVRDAAAIHSQKIGNALRTIDTWYPDEDGLGPIAVEPYGSVTSQGKAYRQPKQKL DFYTLLDNWVLRDEAPAVEQQHYVIANLIRGGVFGEAEEK A0A444M080 RNA (60-MER) Pseudomonas aeruginosa 0.019265403999999996 1 CUAAGAAAUUCACGGCGGGCUUGAUGUCCGCGUCUACCUGGUUCACUGCCGUGUAGGCAG HQ326201.1 CRISPR-associated endonuclease Cas6/Csy4 Pseudomonas aeruginosa 0.021427504 1 Escherichia coli LEVO MDHYLDIRLRPDPEFPPAQLMSVLFGKLHQALVAQGGDRIGVSFPDLDESRSRLGERLRIHASADDLRALLARPWLEGLR DHLQFGEPAVVPHPTPYRQVSRVQAKSNPERLRRRLMRRHDLSEEEARKRIPDTVARALDLPFVTLRSQSTGQHFRLFIR HGPLQVTAEEGGFTCYGLSKGGFVPWF Q02MM2 3.1.-.- anti-CRISPR AcrIF9 Proteus penneri 0.007863849 2 Escherichia coli LEVO MKSTYIIKEVQNINSDREGVKVETTSLTSAKRIASKNQFFHGTVLRIESESGNWLAYKEDGKRWIECE C0AVY5 singleParticle particle 2.5 7.5 20.0 HEPES 100.0 NaCl 2.5 glycerol 1.0 TCEP Quantifoil, UltrAuFoil, R1.2/1.3 GOLD 300 PLASMA CLEANING OTHER
unspecified
 ETHANE 95 277 HOMEMADE PLUNGER FEI TALOS ARCTICA FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 100.0 2.7 0.8 1.2 36000.0 NITROGEN GATAN K2 SUMMIT (4k x 4k) COUNTING 1653 13.2 66.0 1 1571636 C1 3.9 FSC 0.143 CUT-OFF 285707 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_21516.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 200 200 200 0 0 0 200 200 200 230.0 230.0 230.0 90.0 90.0 90.0 X Y Z -0.061401043 0.11653317 -0.000022094737 0.004716737 1.15 1.15 1.15 0.015 AUTHOR anti-CRISPR AcrIF9 bound to the type I-F crRNA-guided CRISPR surveillance complex